/
/
/

Morepen Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2011Mar 2010Mar 2009Mar 2008Mar 2006
₹570 Cr₹485 Cr₹484 Cr₹412 Cr₹425 Cr₹466 Cr₹453 Cr₹438 Cr₹455 Cr₹423 Cr₹445 Cr₹422 Cr₹401 Cr₹364 Cr₹348 Cr₹403 Cr₹302 Cr₹368 Cr₹397 Cr₹395 Cr₹387 Cr₹287 Cr₹307 Cr₹336 Cr₹258 Cr₹207 Cr₹230 Cr₹213 Cr₹203 Cr₹219 Cr₹212 Cr₹174 Cr₹164 Cr₹171 Cr₹155 Cr₹150 Cr₹131 Cr₹60 Cr₹51 Cr₹44 Cr₹39 Cr₹37 Cr
₹5 Cr₹8 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹1 Cr₹87 L₹91 L₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹4 Cr₹1 Cr₹2 Cr₹5 Cr₹3 Cr₹28 L₹1 Cr₹2 Cr₹13 L₹8 L₹30 L₹1 Cr₹86 L₹1 Cr₹0₹0₹0₹38 L₹4 L
₹575 Cr₹493 Cr₹488 Cr₹416 Cr₹430 Cr₹470 Cr₹458 Cr₹443 Cr₹459 Cr₹427 Cr₹449 Cr₹425 Cr₹403 Cr₹367 Cr₹350 Cr₹404 Cr₹303 Cr₹371 Cr₹399 Cr₹398 Cr₹388 Cr₹291 Cr₹310 Cr₹340 Cr₹259 Cr₹208 Cr₹235 Cr₹216 Cr₹203 Cr₹220 Cr₹215 Cr₹174 Cr₹164 Cr₹172 Cr₹156 Cr₹151 Cr₹132 Cr₹60 Cr₹51 Cr₹44 Cr₹40 Cr₹37 Cr
₹496 Cr₹466 Cr₹448 Cr₹392 Cr₹410 Cr₹440 Cr₹422 Cr₹396 Cr₹409 Cr₹384 Cr₹402 Cr₹396 Cr₹383 Cr₹355 Cr₹335 Cr₹381 Cr₹295 Cr₹356 Cr₹371 Cr₹360 Cr₹350 Cr₹263 Cr₹285 Cr₹312 Cr₹239 Cr₹196 Cr₹223 Cr₹207 Cr₹195 Cr₹208 Cr₹205 Cr₹167 Cr₹161 Cr₹164 Cr₹145 Cr₹138 Cr₹129 Cr₹70 Cr₹62 Cr₹52 Cr₹52 Cr₹50 Cr
₹88 Cr₹33 Cr₹50 Cr₹35 Cr₹29 Cr₹47 Cr₹41 Cr₹49 Cr₹55 Cr₹53 Cr₹55 Cr₹37 Cr₹29 Cr₹19 Cr₹22 Cr₹30 Cr₹15 Cr₹22 Cr₹35 Cr₹45 Cr₹45 Cr₹35 Cr₹33 Cr₹35 Cr₹28 Cr₹21 Cr₹20 Cr₹18 Cr₹20 Cr₹23 Cr₹19 Cr₹17 Cr₹12 Cr₹18 Cr₹19 Cr₹20 Cr₹11 Cr₹2 Cr₹1 Cr₹6 Cr₹56 L₹3 Cr
₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹1 Cr₹1 Cr₹1 Cr₹80 L₹2 Cr₹46 L₹28 L₹56 L₹55 L₹47 L₹40 L₹80 L₹75 L-₹9 Cr₹21 L-₹5 L₹1 Cr₹29 L₹29 L₹62 L₹54 L₹39 L₹43 L₹93 L₹43 L₹32 L₹44 L₹81 L₹91 L₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹64 L₹4 L₹15 L
₹75 Cr₹23 Cr₹35 Cr₹46 Cr₹16 Cr₹26 Cr₹35 Cr₹46 Cr₹48 Cr₹42 Cr₹44 Cr₹29 Cr₹21 Cr₹11 Cr₹14 Cr₹22 Cr₹8 Cr₹14 Cr₹27 Cr₹47 Cr₹39 Cr₹28 Cr₹24 Cr₹28 Cr₹20 Cr₹11 Cr₹11 Cr₹9 Cr₹8 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹7 Cr₹10 Cr₹11 Cr₹1 Cr-₹12 Cr-₹13 Cr-₹8 Cr-₹13 Cr-₹13 Cr
₹56 Cr₹16 Cr₹27 Cr₹41 Cr₹11 Cr₹20 Cr₹27 Cr₹35 Cr₹36 Cr₹29 Cr₹32 Cr₹21 Cr₹15 Cr₹8 Cr₹9 Cr₹16 Cr₹6 Cr₹12 Cr₹22 Cr₹37 Cr₹30 Cr₹27 Cr₹24 Cr₹27 Cr₹19 Cr₹11 Cr₹11 Cr₹4 Cr₹8 Cr₹10 Cr₹9 Cr₹7 Cr₹2 Cr₹7 Cr₹10 Cr₹11 Cr₹1 Cr-₹11 Cr-₹13 Cr-₹77 L-₹4 Cr-₹9 Cr

Share Price Live Stats

Open (₹)117.91
Volume (₹)1.76 Cr
High (₹)118.00
Upper Circuit129.19
Low (₹)112.55
Lower Circuit105.71
Prev Close117.45
52W High (₹)118.55
Price113.74
52W Low (₹)33.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)6432.98 Cr
Div. Yield (%)0.17
PE Ratio45.78
Debt to Equity0.07
Price to Book2.27
Book Value21.10
EPS (TTM)2.56
Face Value2.00
ROE (%)11.78

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MOREPENLABNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
113.74+7.55 (7.11%)
100.10
118.55
6,433Cr

Key Highlights of Morepen Laboratories Ltd’s P&L

In 2025-03-31, Morepen Laboratories Ltd reported total revenue of ₹1829.94Cr, compared with ₹1704.4Cr in 2024-03-31, reflecting Morepen Laboratories Ltd turnover.

Depreciation was ₹28.98Cr and finance costs were ₹8.34Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹155.11Cr in 2025-03-31 as compared to ₹135.42Cr in 2024-03-31.

Net Profit (PAT) was ₹118.02Cr in 2025-03-31 compared with ₹96.16Cr in 2024-03-31.

Earnings per share (EPS) were ₹2.15 in 2025-03-31, compared with ₹1.88 in 2024-03-31.